
Company Information
Ask for more detail from the seller
Contact SupplierThe VeriPac 455 core technology is based on the ASTM vacuum decay leak test method (F2338-09) recognized by the FDA as a consensus standard for package integrity testing. The VeriPac 455 features patent pending dual vacuum transducer technology that offers increased test sensitivity and produces very consistent, reliable results.
The VeriPac 455 can be incorporated into protocols at any point in the handling process as it is non-destructive, non-invasive and requires no sample preparation. Applications for this technology include stability studies, clinical trial studies, quality assurance testing and production statistical process control (SPC). The VeriPac 455 is capable of detecting as little as 0.05 cc/min. Results have proven to be superior and more reliable than the dye ingress test.
Â
The VeriPac 455 core technology is based on the ASTM vacuum decay leak test method (F2338-09) recognized by the FDA as a consensus standard for package integrity testing. This test method was developed using VeriPac leak test instruments. The VeriPac 455 features patent pending dual vacuum transducer technology that offers increased test sensitivity and produces very consistent, reliable results. The VeriPac 455 also incorporates significant advances in internet connectivity and networking capabilities that facilitate remote operation, system monitoring and troubleshooting.
Â
Benefits:
Â
Inspection Criteria:
VeriPac 455 is a non-destructive inspection system for highly sensitive micro leak detection of empty & pre-filled syringes, liquid filled & lyophilized vials and other liquid filled packaging (both flexible and rigid).